APA (7th ed.) Citation

Zheng C, Hu X, Zhao L, Hu M, & Gao F. (2017). Clinical and pharmacological hallmarks of rifapentine’s use in diabetes patients with active and latent tuberculosis: Do we know enough? Dove Medical Press.

Chicago Style (17th ed.) Citation

Zheng C, Hu X, Zhao L, Hu M, and Gao F. Clinical and Pharmacological Hallmarks of Rifapentine’s Use in Diabetes Patients with Active and Latent Tuberculosis: Do We Know Enough? Dove Medical Press, 2017.

MLA (9th ed.) Citation

Zheng C, et al. Clinical and Pharmacological Hallmarks of Rifapentine’s Use in Diabetes Patients with Active and Latent Tuberculosis: Do We Know Enough? Dove Medical Press, 2017.